Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement

Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement

To combat infectious diseases, vaccines are considered the best prophylactic strategy for a wide range of the population, but even when vaccines are effective, the administration of therapeutic antibodies against viruses could provide further treatment options, particularly for vulnerable groups who...

Full description

Bibliographic Details
Main Authors: Zenjiro Sampei, Christine Xing’er Koo, Frannie Jiuyi Teo, Ying Xiu Toh, Taku Fukuzawa, Siok Wan Gan, Takeru Nambu, Adrian Ho, Kiyofumi Honda, Tomoyuki Igawa, Fariyal Ahmed, Cheng-I Wang, Katja Fink, Junichi Nezu
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Antibodies
Subjects:
antibody engineering
Fc engineering
anti-virus antibody
complement
C1q
Fcγ receptor
Online Access:https://www.mdpi.com/2073-4468/12/2/36

Internet

https://www.mdpi.com/2073-4468/12/2/36

Similar Items